Related Experiment Video
Updated: Nov 3, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.9K
Developing and user testing new pharmacy label formats-A study to inform labelling standards.
Vivien Tong1, Parisa Aslani1, David K Raynor2
1The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Summary
Patient input improved prescription label design, enhancing safe medicine use. Clearer labels with active ingredients and dosing information help consumers understand and follow medication instructions effectively.
Area of Science:
- Health Sciences
- Patient Safety
- Human-Computer Interaction
Background:
- Prescription medicine labels are crucial for safe and appropriate medication use.
- Effective label design is essential for patient understanding and adherence.
Purpose of the Study:
- To develop and user-test patient-centered prescription label formats.
- To improve the clarity and usability of dispensed prescription medicine labels.
Main Methods:
- Developed 12 prescription label formats for fictitious medicines.
- Conducted two rounds of user testing with consumers (40 in Round 1, 20 in Round 2).
- Assessed participants' ability to find information, understand dosage, and plan a dosing schedule.
Main Results:
- All label formats allowed participants to understand dosage.
- 14/19 labels met industry standards for performance, excluding active ingredient and dosing schedule.
- Clear sign-posting of active ingredients improved identification, and dosing intervals/frequency aided schedule planning.
Conclusions:
- Effective prescription label formatting and active ingredient sign-posting enhance communication.
- Patient and public involvement is critical for developing readable and understandable medicine labels.
- Improved label design can potentially support safer medication use.
Related Concept Videos
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
55
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
55
01:17Drug Nomenclature
2.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.6K
01:28Dosage Regimens: Designs and Approaches
87
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
87
01:25Drug Regulation
2.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.2K
01:10In Vitro Drug Release Testing: Overview, Development and Validation
57
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
57
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
44
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
44